| Class: |
Sympathomimetic |
| Route: |
Subcutaneous |
Adult Dose: |
- Allergic reaction: 0.3 mg - 0.5 mg SQ - standing order, single dose only
- Anaphylactic shock: 0.3 mg – 0.5 mg SQ, every 20 minutes up to 3 doses (including any given by autoinjector) - standing order
- Administer only one dose for bronchospasm unresponsive to nebulizers, CPAP, or magnesium sulfate
|
| Pediatric Dose: |
- Allergic reaction/anaphylactic shock: 0.01 mg/kg (max 0.3 mg per dose) - standing order, single dose only
- Bronchospasm unresponsive to inhaled beta-agonists: 0.01 mg/kg (max 0.3 mg per dose) SQ - BIOTEL AUTHORIZATION ONLY
|
| Drug Action: |
Alpha effects produce peripheral vasoconstriction which:
- Increases coronary and cerebral perfusion
- Increases blood pressure in anaphylaxis
Beta1 effects:
- Increases heart rate
Improves force of ventricular contractions
Beta2 effects produce bronchodilation |
| Onset: |
5 minutes - 10 minutes |
| Duration: |
5 minutes - 10 minutes |
| Indications: |
- Allergic reaction/anaphylactic shock
- Bronchospasm unresponsive to inhaled beta-agonists
|
| Precautions: |
Allergic reaction/anaphylactic shock/refractory bronchospasm:
- Monitor ECG closely
- Patients on beta blockers may need glucagon or higher doses of epinephrine
|
| Side Effects: |
Anaphylaxis:
- Tachycardia
- Ventricular arrhythmias
- Headache
- Flushing
- Nausea/vomiting
- Chest pain
|
| Contraindications: |
- Allergic reaction: None
- Refractory bronchospasm: Heart disease, History of AMI, Age > 45 years, Arrhythmia, Labor
|